Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23619)

• Formulation Name: Amifampridine 10 mg tablet
• Company: Catalyst Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Amifampridine	(DMK08L3)	LambertEaton myasthenic syndrome	8C62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium stearate	(E00244)	15324	lubricant
Cellulose microcrystalline	(E00698)	Not Available	Adsorbent; Suspending agent; Diluent
Hydrophobic colloidal silica	(E00285)	24261	Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent